Axa S.A. Protagonist Therapeutics, Inc Transaction History

Axa S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$18.02 - $29.36 $1.34 Million - $2.19 Million	-74,600 Reduced 86.24%	11,900 $328,000
Q1 2023 May 15, 2023	SELL	$10.78 - $25.38 $228,536 - $538,056	-21,200 Reduced 19.68%	86,500 $1.99 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $846,522 - $1.26 Million	107,700 New	107,700 $908,000

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.